首页> 美国卫生研究院文献>Nature Communications >Adenovirus prime Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
【2h】

Adenovirus prime Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys

机译:腺病毒初免Env蛋白加强疫苗可保护猕猴中抗中和性的SIVsmE660变体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have shown that DNA prime, Ad5 boost vaccines protect against neutralization-sensitive but not neutralization-resistant virus variants within the SIVsmE660 swarm. Here we show that Ad prime, Env protein boost vaccines protect against neutralization-resistant SIVsmE660 variants. We perform two studies in rhesus monkeys with Ad35/Ad26 vectors expressing SIVmac239 Gag/Pol/Env with or without an AS01B-adjuvanted SIVmac32H gp140 protein boost. In a repetitive, low-dose challenge study, we observe robust protection against acquisition of infection by both Ad Alone and Ad/Env vaccines. In a single, high-dose challenge study, only the Ad/Env vaccine affords significant protection against acquisition of infection. Analysis of transmitted/founder (T/F) viruses from this study demonstrates that the Ad/Env vaccine blocks both neutralization-sensitive and neutralization-resistant SIVsmE660 variants in rhesus monkeys with restrictive TRIM5α alleles. These data demonstrate that the adjuvanted Env protein boost is critical for protecting against high-dose SIVsmE660 challenge and for blocking neutralization-resistant viruses within the SIVsmE660 swarm.
机译:先前的研究表明,DNA原始Ad5加强疫苗可抵抗SIVsmE660群中的中和敏感但不具有中和抵抗力的病毒变体。在这里,我们显示了Ad Prime Env蛋白加强疫苗可抵抗中和性抗SIVsmE660变体。我们用表达SIVmac239 Gag / Pol / Env的Ad35 / Ad26载体在有或没有AS01B辅助SIVmac32H gp140蛋白增强的Ad35 / Ad26载体中对恒河猴进行两项研究。在一项重复的小剂量攻击研究中,我们观察到了强大的保护作用,可防止单独接种Ad和En / Env疫苗感染。在一项高剂量挑战研究中,只有Ad / Env疫苗可提供重要的保护,防止感染。这项研究对传播/基础(T / F)病毒的分析表明,Ad / Env疫苗可在具有限制性TRIM5α等位基因的恒河猴中阻断中和敏感性和中和抵抗力的SIVsmE660变体。这些数据表明,佐剂化的Env蛋白增强对于抵御高剂量SIVsmE660攻击和阻断SIVsmE660群内的抗中和性病毒至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号